Background and Purpose-Hypothermia has been shown to be neuroprotective in a variety of clinical settings.
T he cerebroprotective effects of hypothermia are well known. [1] [2] [3] [4] Safe and effective administration of this strategy, however, has remained elusive. Achievement of mild hypothermia through the use of surface cooling techniques has a slow onset because of peripheral vasoconstriction 5, 6 and typically fails to reduce the brain to core temperature. 7 Additionally, surface cooling procedures are complicated by the phenomenon of rewarming afterdrop 8 and may cause cerebral swelling during the rewarming period. 9 Equally limiting have been the deleterious side effects associated with total body hypothermia, including cardiac arrhythmias, 10 -12 coagulopathy, 13, 14 hemolysis, 15 renal and hepatic dysfunction, 16, 17 and immunosuppression. 18 -20 To avoid the systemic complications of total body cooling, investigators have attempted selective cerebral hypothermia. External cooling devices have proved effective in selectively cooling the brain in small animals. 21 Unfortunately, mathematical modeling and in vivo experiments have demonstrated failure to selectively cool the brains of larger animals. 22 Additional studies have confirmed the indolence of these techniques, 23 along with their inability to reach deep cerebral regions. 23 In contrast, extracorporeal cerebral bypass hypothermia is effective in achieving selective brain cooling. Unfortunately, this technique requires heparinization; is complicated by vascular trauma, embolization, and idiopathic cerebral edema; and has been abandoned as unsafe and impractical. 24 -26 These investigations, together with the recent failure of mild hypothermia in the setting of severe head trauma in humans, 6, 27, 28 have emphasized the need for a safer, more effective means of achieving cerebral hypothermia. We have developed a catheter featuring a highly conductive metallic tip that incorporates the principles of direct heat transfer within the great vessels. This enables tightly regulated intravascular tissue cooling and rewarming. Unlike existing arteriovenous or venovenous bypass circuits, the design of the catheter is based on contemporary over-the-wire, coaxial endovascular devices and is highly flexible, facilitating its percutaneous placement in a variety of vascular beds. Here, we describe the ability of this catheter to rapidly and safely achieve reproducible total body cooling in a nonhuman primate model of stroke.
Methods

Animals
Sixteen male baboons (Papio anubis; Buckshire Farms; 21.1Ϯ0.9 kg) were included in this series after an appropriate period of quarantine and observation. All animal care and experimental procedures were approved by the Institutional Animal Care and Use Committee and were performed in accordance with the National Institutes of Health (NIH) Guidelines for the Care and Use of Laboratory Animals.
Anesthesia
Animals were subjected to anesthesia and monitoring as previously described. 29 Baboons were anesthetized with 5 mg/kg IM ketamine (Fort Dodge Animal Health). Two 18-gauge peripheral venous catheters were placed, and intravenous fluid administration of 0.9% normal saline was begun. Propofol (Zeneca Pharmaceutical) was given as a bolus infusion before oropharyngeal intubation. Animals were transferred to an operating room and were begun on assisted ventilation (Ohmeda 7000 ventilator) with an inhalational mixture of isoflurane (Baxter) and balanced nitrous oxide and oxygen. Animals were securely placed into a head frame (Stoelting) in the prone position. In anticipation of placing additional monitoring devices, an intravenous bolus infusion of fentanyl (Elkin-Sims) at 50 g/kg was given, followed by a continuous infusion of 50 to 70 g · kg Ϫ1 · h Ϫ1 . The concentration of isoflurane was maintained between 0% and 0.6%. Intravenous cefazolin (Bristol/Myers Squibb) was administered for antibiotic prophylaxis. Before final positioning, a continuous intravenous vecuronium infusion (Organon) was started at 0.04 mg · kg Ϫ1 · h Ϫ1 . At the initiation of the transorbital approach, the rate of fentanyl infusion was increased to 70 to 100 g · kg Ϫ1 · h Ϫ1 , and the isoflurane was decreased to Ͻ0.5%.
Physiology
An intra-arterial catheter was introduced into the femoral artery for continuous systemic blood pressure monitoring and multiple blood specimen collections at baseline, during ischemia, and during reperfusion. Mean arterial blood pressure (MABP) and heart rate were monitored. Hypotension was treated with intravenous bolus injections of phenylephrine hydrochloride (Gensia Laboratories) to maintain an MABP of 60 to 80 mm Hg. An indwelling Foley catheter (Baxter) was placed for urinary output monitoring and guidance of fluid management. Arterial blood gas analysis (PCO 2 , pH, PO 2 ) was performed at regular intervals (Stat Profile 3, Nova Biomedical). The respiratory rate and tidal volume were adjusted to keep PCO at 35 to 40 mm Hg. Cerebral parenchymal temperature probes were positioned bilaterally through precoronal burr holes. Core temperature was monitored by placement of an esophageal temperature probe (Mallinckrodt Inc). Continuous intracranial pressure (ICP) monitoring was accomplished with a parenchymal sensor (Neuromonitor, Codman) placed in the right frontal lobe. Sustained ICP of Ͼ20 mm Hg for Ͼ5 minutes was treated with 0.5 g/kg mannitol as an intravenous bolus infusion.
Motor evoked potentials (MEPs) were monitored by applying transcranial electric stimulation to the motor cortex and recording compound muscle action potentials from the forelimbs. Adequacy and uniformity of cerebral ischemia were ascertained by stimulating the ipsilateral ischemic hemisphere and noting contralateral limb MEP dropout with the use of stimuli strong enough to stimulate the contralateral (nonischemic) hemisphere and produce ipsilateral limb MEP.
Reperfused Stroke
Animals were subjected to middle cerebral artery territory reperfused stroke as previously described by Huang et al. 29 Briefly, they underwent orbital exenteration and removal of the posterior-medial orbital wall under the microscope (Super-Lux 40-2 Illuminator, Zeiss). Dura was opened, and the cerebral arteries were identified.
Vessel occlusion was accomplished by sequential placement of micro-Yasargil (Aesculap) aneurysm clips on the left anterior cerebral artery proximal to the anterior communicating artery, on the proximal right anterior cerebral artery, and across the left internal carotic artery at the level of (occluding) the anterior choroidal artery. Vessel occlusion was maintained for 1 hour. Clips were then removed to allow reperfusion.
Hypothermia
Hypothermia was induced in the experimental cohort (nϭ8) by use of a novel heat-transfer catheter (Innercool Therapies, Inc; Figure 1 ). This catheter, described previously in a porcine model of intravascular hypothermia, 30 was designed to provide precise, stable, and rapid cooling. The catheter was placed intravenously through the femoral vein into the inferior vena cava. Cooling to a target temperature of 32°C was initiated 3 hours (185.3Ϯ17.5 minutes) after the onset of ischemia and continued for a total of 6 hours. Core temperature was used as feedback to control the cooling system, and core and brain temperatures were recorded throughout stroke induction, reperfusion, cooling, and rewarming at 1 Hz (National Instruments). After treatment, the catheter was removed from the vasculature and examined for adherent thrombus. Animals were slowly rewarmed (1.0Ϯ0.1°C/h) to normal core temperature (36.5Ϯ0.5°C) over 6 hours with surface heating blankets (Mallinckrodt Inc). Control animals (nϭ8) underwent no cooling and were maintained in the normothermic range (36.7Ϯ0.5°C) with heating blankets. 
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Blood samples from 4 animals in each group were analyzed for hematocrit, white blood cell count, platelet count, blood glucose, and serum chemistry. Samples were drawn from control animals at baseline, during ischemia, and during reperfusion (12 hours after ischemia). In the hypothermic animals, blood was drawn at baseline, during ischemia, at core temperature of 32°C, during rewarming, and at 12 hours after ischemia (normothermia).
Neurological Outcome
Animals were assessed postoperatively on a daily basis with the 100-point Spetzler scale, 31 with higher scores representing better functional outcomes. Motor function was graded from 1 to 75, according to severity of hemiparesis in the extremities (10ϭsevere, 25ϭmild, 55ϭfavors normal side, and 70ϭnormal) and face (1ϭfa-cial paresis and 5ϭnormal facial strength). Behavior and alertness were scored from 0 to 20 (0ϭdead, 1ϭcomatose, 5ϭaware but inactive, 15ϭaware but less active, and 20ϭnormal), and visual field deficits were assigned 1 if present or 5 if absent.
Radiographic Imaging
T2-weighted MRI was performed on sedated animals to measure infarct volume at early (72 hours) and late (9 to 10 days) time points, as previously described. 29 Animals were anesthetized with ketamine and sedated with an intravenous pentobarbital bolus and propofol infusion that was titrated to allow independent respiratory function while the airway was maintained with an endotracheal tube. Brain MRI was performed (Signa Advantage, 1.5 T, General Electric) to obtain coronal T2-weighted images with a slice thickness of 3 mm without intervening tissue. T2 characteristics included the following: repetition time, 3000 ms; echo time, 105 ms; excitation, 1; echo train length, 10; field of view, 20ϫ15; and matrix, 256ϫ192. Hypothermic animals also underwent 12-hour gradient-echo and diffusionweighted imaging to assess for early stroke volume and the presence of hemorrhagic conversion. Digital planimetric analysis (Adobe Photoshop 4.0 and NIH Image) was performed by 2 independent observers to quantify infarct volume (percent ipsilateral hemisphere).
Euthanasia
Animals incapable of self-caring at 72 hours were euthanized early. All other animals were euthanized late (maximum duration, 10 days). Animals were euthanized with intravenous pentobarbital (Veterinary Laboratories). After euthanasia, animals were perfused intra-arterially with 1 L heparinized saline at 4°C followed by 1 L heparinized paraformaldehyde at 4°C for tissue fixation. Brains were then removed intact and preserved in paraformaldehyde at room temperature.
Statistical Analysis
Ability to self-care was determined for all animals at 72 hours. 
Results
Hypothermia
Cooling was achieved at a rate of 6.3Ϯ0.8°C/h ( Figure 2 ). Target brain temperatures (32.2Ϯ0.2°C) were reached at the same time (47.7Ϯ6.32 minutes) as target esophageal temperatures (32.0Ϯ0.0°C). Hypothermia was maintained for 6 hours in all animals. Animals were rewarmed at a rate of 1.0Ϯ0.1°C/h until the target core temperature of 36.15Ϯ0.2°C was attained. Twelve hours after reperfusion, hypothermic animals underwent gradient-echo MRI, which revealed no hemorrhagic conversion of the infarct. There were no episodes of cardiac arrhythmias during hypothermia or rewarming. Postoperative monitoring and postmortem analysis of animals revealed no evidence of infection, venous thrombosis, or injury related to catheter placement. There was 1 death before euthanasia and 72-hour scanning in the hypothermia cohort, presumably because of iatrogenic propofol overdose. Hypothermia treatment had ceased 1 day earlier, after which time the baboon had reached normothermia and did not demonstrate any overt residual effects. The animal exhibited normal behavior during the early postoperative period. This baboon was included in the group of animals unable to self-care at 72 hours (see the Outcome section). Because 72-hour or sacrifice infarct volumes and functional assessments could not be obtained, data from this animal did not contribute to imaging and neurological score analysis. In addition, 1 of the animals in the hypothermic cohort had no 72-hour MRI secondary to technical difficulties in the scanning facility. However, this baboon did have 24-hour diffusion-weighted imaging and 10-day T2-weighted MRI.
Physiology
The Table presents physiological variables at baseline, during ischemia, and during early reperfusion for the control and hypothermia cohorts. PCO values were maintained in the range of 35 to 40 mm Hg throughout the study. No differences existed in pH and PO measurements across cohorts (PϭNS). MABP was titrated to 60 to 80 mm Hg by fluid balance, anesthetic management, and a phenylephrine hydro- chloride drip. Heart rate remained between 70 and 100 bpm (PϭNS between cohorts). Hematocrit, white blood cell counts, platelet counts, blood glucose, and serum chemistries were similar for the hypothermic and normothermic cohorts throughout the experiment (PϭNS between cohorts). ICP in both hypothermic and normothermic cohorts increased steadily during the perioperative period. The mean postoperative ICP for the hypothermia cohort was not significantly different from that of controls (PϭNS; Figure 3A ).
Outcome
Seventy-five percent of hypothermic animals (6 of 8) were capable of feeding themselves and holding themselves upright at 72 hours, whereas 38% of control animals (3 of 8) were self-caring (Pϭ0.31; Figure 3B ). One baboon in the hypothermia cohort (self-sufficient at 72 hours) was deemed unable to feed himself on day 6 and was therefore euthanized at that time (30% 6-day infarct). At 72 hours, the hypothermia cohort (nϭ6) demonstrated a 17Ϯ8% infarct volume, and the control group (nϭ8) had a mean infarct volume of 32Ϯ9% (Pϭ0.12; Figure 4A ). At 9 to 10 days, the hypothermia cohort (nϭ5) exhibited a mean infarct volume of 10Ϯ4%, whereas the control group (nϭ2) had a mean infarct volume of 9Ϯ4% (Pϭ0.30). There was a strong correlation between neurological score and infarct volume (rϭϪ0.807, PϽ0.005) for all animals. At 72 hours, the hypothermia cohort (nϭ7) had a mean neurological score of 42Ϯ9, whereas the control group (nϭ8) had a mean neurological score of 29Ϯ8 (Pϭ0.30; Figure 4B ). At 9 to 10 days, the hypothermia cohort (nϭ5) exhibited a mean neurological score of 58Ϯ9, whereas the control group (nϭ2) had a mean neurological score of 64Ϯ32% (Pϭ0.80). Only animals capable of survival past 72 hours were included in 9 to 10 -day infarct volume and neurological outcome analyses. Therefore, the number of baboons (control, nϭ2; hypothermia, nϭ5) in this cohort 
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was very small, and the data were biased by those capable of survival.
Discussion
Recently, Behringer et al 32 reviewed current cooling methods and recognized the need for a more reliable means of hypothermia delivery. They demonstrated that in large dogs, the induction of mild systemic hypothermia with extracorporeal venovenous blood shunt cooling could be achieved 4 times more rapidly than with skin surface techniques. Although the authors do not attempt to assess an effect on the course of neurological disease, their results underscore the importance of efficient hypothermia administration. They suggest using the needle-wire method of Seldinger for easyaccess insertion of catheters into the vena cava in future investigations. 32 Using such a technique, our study describes the performance of an endovascular catheter that enables whole-body cooling by harnessing the principle of convective heat transfer. This approach results in a 5-fold increase in cooling rates compared with surface methods and many non-convectionenhanced intravascular strategies. 33 Moreover, this cooling technique is applicable at clinically relevant time points (3 hours after ischemia). Although previous studies demonstrate that hypothermia increases cerebral ischemic tolerance in rodents, this is the first report of safe and efficient hypothermia administration in baboons. This strategy underscores the potential for successful application of hypothermia as a cerebroprotective agent in primate stroke. An abundance of therapies that have proved protective in small animal models of ischemia have failed in clinical trials. Poor outcomes have raised ethical concerns and emphasize the importance of successful translation in nonhuman primate stroke models. 34, 35 The findings of our study are timely, given the recently published efficacy of mild therapeutic hypothermia in survivors of cardiac arrest. Two separate randomized clinical trials reported improved outcomes in comatose patients after resuscitation from out-of-hospital cardiac arrest. 36, 37 There have been multiple preliminary reports of the potential utility of hypothermia in patients with stroke despite the highly publicized failure of a well-designed multicenter NIH-funded head trauma hypothermia trial. 7, 28, 38, 39 What is clear from the small case series of hypothermia in human stroke and the multicenter head trauma trial is that current surface or nonconvective catheter techniques are probably too slow and/or inconsistent to be efficacious. 40, 41 In addition, the neuroprotective benefits in these studies may have been negated by hypothermia-associated cardiac instability, hypotension, coagulopathy, fever, infection, and cerebral edema. In these studies, the duration of hypothermia was prolonged, usually 48 hours. Despite such complications, several groups continue to advocate the use of prolonged cooling. In the late 1970s, Steen and colleagues 42 treated primates with 48 hours of 29°C hypothermia, which resulted in worsened outcome. Our data suggests that prolonged use of hypothermia may be unnecessary. This study yielded a 50% reduction in 72-hour infarct volume without any complications when hypothermia was maintained for only 6 hours.
More definitive nonhuman primate studies may determine, with greater statistical strength, the optimal therapeutic window and treatment duration before large-scale hypothermia trials in human stroke. The catheter described here will likely enhance the efficacy of clinical studies by enabling rapid and precise temperature control and delivery. A brief episode of mild core hypothermia instituted at a clinically relevant time point with the described intravascular cooling technique provides safe, rapid, reproducible hypothermia. The development of convection-enhanced intravascular cooling marks a paradigm shift in hypothermia administration and has implications for the management of tissue injury in a variety of organ systems and settings. 
